Veracyte: Veracyte's new trial data shows accuracy in WGSbased MRD testing platform for muscleinvasive bladder cancer
Veracyte, Inc, a leading cancer diagnostics company, announced new data showing that its whole─genome sequencing (WGS)─based platform for minimal residual disease (MRD) testing detected cancer in patients treated
Read full article »
Veracyte is a California-based genomic diagnostics company that develops molecular diagnostic tests for the healthcare industry.
Read more